Reddit Posts
Part two- been practicing option trading (80 % success rate)
Election year. Trump stocks and Biden stocks
YOLO Alert: Boeing on the Brink – Why WSB Traders Should Short the Skies
Cancer treatment that destroys 99% of cancer cells. Bullish on Biotech cancer stocks like $JNJ?
If you had $40k to invest right now, what would you do with it?
$RNXT $1.00 +25.63% #Cancer #Treatment #Research
$TMGI Shareholder letter coming early next week with exciting updates
Berkshire releases updated holdings. Goodbye GM, JNJ, hello…SIRI?
Opinions on Pfizer, JNJ, Cummins, Wells Fargo, Deere, PPG
BNOX - Bionomics Shares In Rally Mode As Investors Take Interest Ahead Of Planned Phase III Trial To Treat PTSD And SAD ($BNOX)
$NRXS IBS treatment with less side effects than their competitors
$AMZN , $META , $JNJ all trades profitable today , guys are "you" all making money??🤔
$AMZN , $META , $JNJ all trades profitable today , guys are "you" making money??🤔
I Hate what the market has turned into but KVUE/JNJ is a lil wild
Advice please: Dump JNJ and OMER? RHHBY? It's an IRA so I can't just add $ but looking to improve as much as possible with what's in the account (my risk tolerance is moderately high). Appreciate any/all help!
Johnson & Johnson Earnings Are Here: Should You Buy?
2023-04-11 Wrinkle Brain Plays - In the style of Abraham Lincoln
Future of JNJ with Consumer spinoff (Kenvue)
2023-04-06 Wrinkle Brain Plays - In the style of Buzz Lightyear
Crude Oil Crosses $80, AMC Descends To Its Death, And Much More... Stock Market News Today (04/04/23)
Crude Oil Crosses $80, AMC Descends To Its Death, And Much More | Stock Market News Today (04/04/23)
Crude Oil Crosses $80, AMC Descends To Its Death, And Much More | Stock Market News Today (04/04/23)
A market-cap weighted index of the five top-rated Dow stocks yielding at least 2% as of Feb. 14, 2022 is beating the market by 20 percentage points.
Unusual Options Activity. JNJ July 165calls. I think this guy has an idea.
Johnson & Johnson wins EU nod for prostate cancer therapy (NYSE:JNJ)
5 Best Stocks to Buy and Hold for a Lifetime.
Johnson & Johnson succeeds in mid-stage trial for fetal disorder candidate (NYSE:JNJ)
Ambulatory surgery centers, robotics seen as trends for orthopedic devices in 2023 (JNJ)
Novavax, JNJ dispute pre-payments for cancelled COVID shots for world’s poor (NASDAQ:NVAX)
Most Important News from Today in the Stock Market
Most Important News from Today in the Stock Market
Most Important News from Today in the Stock Market
Most Important News from Today in the Stock Market
Technical Analysis & Trades: SPY QQQ IWM // JNJ LMT CVS
Johnson & Johnson Q4 Adjusted Profit Rises; Sales Drop; Full-Year 2023 Guidance Released
Technical Analysis & Trades: SPY QQQ IWM // NFLX JNJ LMT UUP
Is anyone aware of a tool to find negative Beta stocks relative to another stock?
"$CEMI - CHEMBIO DIAGNOSTICS - BUY UNDER .50"
Will so many positive earnings surprises fool investors in thinking inflation isn't a problem?
"$CEMI - BUY UNDER .50 BEFORE THE NEXT P.R. TRIPLES THE SHARE PRICE"
"$CEMI - Chembio Diagnostics - Buy Under .50"
Johnson and Johnson about to move into autologous stem-cell therapies?
Mentions
people stop speculating when the market gets spooked and go to safe stocks like Procter & Gamble (P&G), Coca-Cola (KO), and Johnson & Johnson (JNJ), which typically trade at a Price-to-Earnings (P/E) ratio under 20
https://preview.redd.it/70s57sathbzf1.png?width=1344&format=png&auto=webp&s=7b196c27130b3ec5023dab519af948a85b37f005 34% drawdown on this specific set for 670s is roughly $5k in size. Keep in mind these trades pictured are only for SPY & Qs. I am also short a few other names like NVDA, SMH, AMZN, AAPL, BAC, JNJ, etc...
Nah it has nothing to do with trumps drop. The lawsuits in the uk are a massive liability that is the reason the company split from JNJ. Lawsuits for asbestos in the talc.
Im a vascular IR RN. Its cool tech. Super small demographic. Tons of pharma solutions for clots that dont require a level 1. JNJ shockwave has a larger customer base potential.
Not a JNJ attorney but typical reasons for not settling these early include: 1) too high of a demand from the plaintiff; 2) uncertain liability exposure; 3) other co-defendants who share some portion of liability; 4) they don’t want to set a precedent of eagerly settling claims; and/or 5) the financial risk makes it worth trying the case and hoping for a defense verdict.
I believe SMWB is an outstanding under covered stock. 100% recurring revenues from subscription data services that are growing 15-17% new subscriptions every year. 45% of the subscriptions are multiple year. 80% gross margins and only trading at 2X their revenue They are cash flow positive and expect at $400mm revenue margins will be 25%. Their data is used by global enterprises to do competitive analysis and adjust go to market strategies between web, mobile, Gen AI They serve clients in all industries from Google to JNJ to Coke to DHL to GM to JP Morgan etc. Their data is constantly updated with their feeds from global internet locations - and the AI Models Pay SMWB to feed their analyses - they need the constantly updated data. It’s an $8 stock that will earn at least $1 in a few years - and likely will get a 25-30X multiple for a high margin, growing, capital light, global data recurring subscription standard.
My wife and I are in healthcare and work with this population. Not only are they not the sole market leader, they have lots of competition in that particular area of medicine. I have friends that work for competitor companies (JNJ, Medtronic), so I get to hear about all the upcoming “will change medicine” technologies they are working on. Most of these technologies will never become successful. And the ones that do have a relatively small market and a very slow uptake rate. I personally would never invest in medical technology companies. It’s too difficult to predict which ones will see stock gains, and usually those gains are short lived.
JNJ owns the liability for the baby powder lawsuits, not KVUE
I own 500 shares at 16 dollars. Strong brands, mature business and very good dividend. I’ve looked into the lawsuits and I honestly believe they don’t matter. The Tylenol one is dumb. They’re only stuck with non-US and Canada talc lawsuits and my view is that it’s fine, damages are only outrageous in the US and JNJ is being able to reduce payments on those significantly in appeals. I am cautiously optimistic for the new CEO search. If they get much lower than this, they’ll get bought. So I am still very confident in my investment.
Personally, I stuck with JNJ fully because KVUE is actually a commoditized business with the only value being brand names - just too much generic competition.
Why isn’t JNJ actively trying to settle these before going deep into litigation? Why would they ever risk going to a decision? Or is this just a blood in the water situation and no one is willing to ate to an early settlement?
I believe SMWB is an outstanding under covered stock. 100% recurring revenues from subscription data services that are growing 15-17% new subscriptions every year. 45% of the subscriptions are multiple year. 80% gross margins and only trading at 2X their revenue They are cash flow positive and expect at $400mm revenue margins will be 25%. Their data is used by global enterprises to do competitive analysis and adjust go to market strategies between web, mobile, Gen AI They serve clients in all industries from Google to JNJ to Coke to DHL to GM to JP Morgan etc. Their data is constantly updated with their feeds from global internet locations - and the AI Models Pay SMWB to feed their analyses - they need the constantly updated data. It’s an $8 stock that will earn at least $1 in a few years - and likely will get a 25-30X multiple for a high margin, growing, capital light, global data recurring subscription standard.
Not entirely sure how the whole: "it goes down when the dividends are paid" works since I invest on ETFS right now, Dividend & Growth etfs, but the price of companies don't necessarily go down all that much or if they do it might be for a week or so. Just basing this on stocks like JNJ, PG, PEP and ABBV. They only keep going up and they pay $1/share per dividend payout and their stocks don't necessarily go down one dollar for long. I do have reservations investing on anything thats on the red during their 5 year to MAX tenure graphs. Though if I'm incorrect I'd appreciate a clarification since that could help with deciding better company stocks.
As a defense attorney I don’t agree with it either. Especially because it is virtually impossible to identify the asbestos contents of products that were distributed 50+ years ago. I saw the JNJ verdict read live yesterday, couldn’t believe it. I have clients who are being sued in asbestos litigation where the territories that the alleged exposure took place weren’t even in their distribution chains.
$JNJ is done. There are tens of thousands of lawsuits pending against JNJ for alleged asbestos exposure due to the talc contained in their powder products, which wasn’t discontinued until 2020. In October 2025, a Los Angeles jury ordered JNJ to pay $966 million in a talc/mesothelioma case for a woman who died of mesothelioma, finding asbestos in the talc product.  Earlier in 2025, a Massachusetts jury awarded $42.6 million to a man who developed mesothelioma after using JNJ baby powder.  There are also numerous other verdicts: a $260 million verdict in Oregon (June 2024), a $45 million verdict in Illinois (April 2024) for a mesothelioma wrongful-death case, and a $20 million verdict in Broward County, FL against JNJ was rendered yesterday afternoon.  Forget about the Tylenol case, asbestos litigation is what will drive $JNJ into the ground.
More than 60,000 lawsuits are pending against JNJ in the U.S. for talc-related claims. In October 2025, a Los Angeles jury ordered JNJ to pay $966 million in a talc/mesothelioma case for a woman who died of mesothelioma, finding asbestos in the talc product.  Earlier in 2025, a Massachusetts jury awarded $42.6 million to a man who developed mesothelioma after using JNJ baby powder.  There are also numerous other verdicts: a $260 million verdict in Oregon (June 2024), a $45 million verdict in Illinois (April 2024) for a mesothelioma wrongful-death case, and a $20 million verdict in Broward County, FL against JNJ was rendered yesterday afternoon.  With tens of thousands of pending lawsuits the sheer scale amplifies exposure. Even modest per-claim settlements or judgments can aggregate to multi-billion-dollar sums. Also, Texas just sued JNJ for the risks associated with Tylenol, which serves as even more exposure. I don’t see a way for $JNJ to be a safe play by any means.
Instructions unclear, down 70% on JNJ call from yesterday (was up 30% at one point:( Is this when I sell or do I hold till Fri?
Have a look at their annual report my dude. Page 32 has a full description of the risk and they have another description surrounding their relationship with JNJ. Just copying a few paragraphs that may be interesting for you. In October 2021, Old JJCI implemented a corporate restructuring, as a result of which LTL Management LLC (“LTL”), a subsidiary of J&J, was established through a demerger procedure and assumed sole responsibility for all liabilities of Old JJCI related in any way to injury or damage, or alleged injury or damage, sustained or incurred in the purchase or use of, or exposure to, talc, including talc contained in any product sold in the United States or Canada, or to the risk of, or responsibility for, any such damage or injury, including such liabilities based on the contamination, or alleged contamination, of talc, including talc contained in any product sold in the United States and Canada, with asbestos or any other material (the “Talc-Related Liabilities”). Pursuant to the Separation Agreement, J&J has retained the Talc-Related Liabilities and, as a result, has agreed to indemnify us for the Talc-Related Liabilities and any costs associated with resolving such claims. Such claims represent the vast majority of claims relating to harm arising out of, based upon or resulting from, directly or indirectly, the presence of or exposure to talc or talc-containing products. However, we remain responsible for all liabilities on account of or relating to harm arising out of, based upon or resulting from, directly or indirectly, the presence of or exposure to talc or talc-containing products sold outside the United States or Canada. LTL remains a subsidiary of J&J (and not Kenvue) following the Separation. 32 We cannot predict with certainty the amount or timing of Talc-Related Liabilities that LTL or J&J will be required to pay, whether in connection with the bankruptcy proceedings or otherwise. Various parties have brought, and it is possible that other parties will seek to bring, claims against us, including by raising allegations that we are liable for the Talc-Related Liabilities, and it is possible that these parties will be successful in bringing such claims. Although, under the Separation Agreement, J&J has agreed to indemnify us for the Talc-Related Liabilities and any costs associated with resolving such claims, we cannot assure you that the indemnity from J&J will be sufficient to protect us against the full amount of these liabilities or that J&J will be able to fully satisfy its indemnification obligations. See “— Risks Related to Our Relationship with J&J—In connection with the Separation, J&J agreed to indemnify us for certain liabilities. However, we cannot assure you that the indemnity will be sufficient to protect us against the full amount of such liabilities or that J&J’s ability to satisfy its indemnification obligation will not be impaired in the future.”
The lawsuit was about JNJ knowing there was a possibility that their talc powers were contaminated with cancer causing asbestos, and doing nothing to inform the public of the risk. The two aren’t the same because science has already proven that asbestos is a cancer causing agent, and lawyers everywhere know saying otherwise in court is not going to fly. The same can’t be said for acetaminophen. The plaintiff will need to be able to use evidence to demonstrate to a jury that, 1) acetaminophen causes cancer, 2) Kenvue knew that acetaminophen causes cancer and sold it anyway. This lawsuit is the equivalent of a political stunt and will very likely lead to counter suits. (Just like all those voting machine fraud allegations lead to counter lawsuits a couple elections back)
Texas AG suing KVUE and JNJ over Tylenol autism link lol
This is such an obvious pump and dump. Don Cheeto is pissed that JNJ didn't want to play ball like Pfizer for his grift site so he is tanking the stock him and a bunch of friends are get in after all the negative news piles in then surprise cased dismissed don pulls a taco and the pump and dump ensues
Because that's the precedent. JNJ got sued over talc powder despite there being no conclusive evidence that it caused cancer. Why? Because they can't prove that it didn't cause cancer. They have tried to settle multiple times for Billions of dollars, and been shot down every time.
The Tylenol murders were caused by this dude that tampered with the Tylenol bottles at a store. He even confessed and tried to extort money from JNJ through it, the DOJ files indicate that they were pretty sure he did it but didn’t have sufficient evidence to charge him.
Notable Option Flow Recap Big money still pouring into multiple sectors today 👇 • $BULL 35C (11/21/2025) – 💰 $431K @ 0.12 avg | 204% OTM • $EOSE 21C (01/16/2026) – ⚡ $814K @ 2.06 avg | 31% OTM (ER in 11 D) • $GM 80C (03/20/2026) – 🚗 $2.3M @ 2.19 avg | 15% OTM • $HUT 75C (01/15/2027) – 💻 $2.2M @ 14.23 avg | 57% OTM (ER in 11 D) • $JNJ 195C (11/21/2025) – 🧬 $1.9M @ 1.64 avg • $PATH 20C (01/16/2026) – 🤖 $19.6M @ 1.30 avg | 21% OTM • $PDD 138C (11/28/2025) – 🛍️ $14.3M @ 5.09 avg • $RDDT 250C (11/07/2025) – 💬 $2.4M @ 6.59 avg | 17% OTM (ER in 6 D) • $TLT 94C (03/31/2026) – 🏦 $2.7M @ 1.96 avg • $UUUU 33C (10/31/2025) – ☢️ $387K @ 1.27 avg | 54% OTM (Buzzer Beater) 🧠 Smart money spreading risk across growth, energy, and macro trades — both short-term momentum and long-dated conviction plays. 💡 Simplest way to see what the big boys are doing — use real-time AI data from Perplexity Browser 👇 👉 https://pplx.ai/maxmasoodi63049
Notable Option Flow Recap Big money still pouring into multiple sectors today 👇 • $BULL 35C (11/21/2025) – 💰 $431K @ 0.12 avg | 204% OTM • $EOSE 21C (01/16/2026) – ⚡ $814K @ 2.06 avg | 31% OTM (ER in 11 D) • $GM 80C (03/20/2026) – 🚗 $2.3M @ 2.19 avg | 15% OTM • $HUT 75C (01/15/2027) – 💻 $2.2M @ 14.23 avg | 57% OTM (ER in 11 D) • $JNJ 195C (11/21/2025) – 🧬 $1.9M @ 1.64 avg • $PATH 20C (01/16/2026) – 🤖 $19.6M @ 1.30 avg | 21% OTM • $PDD 138C (11/28/2025) – 🛍️ $14.3M @ 5.09 avg • $RDDT 250C (11/07/2025) – 💬 $2.4M @ 6.59 avg | 17% OTM (ER in 6 D) • $TLT 94C (03/31/2026) – 🏦 $2.7M @ 1.96 avg • $UUUU 33C (10/31/2025) – ☢️ $387K @ 1.27 avg | 54% OTM (Buzzer Beater) 🧠 Smart money spreading risk across growth, energy, and macro trades — both short-term momentum and long-dated conviction plays. 💡 Simplest way to see what the big boys are doing — use real-time AI data from Perplexity Browser 👇 👉 https://pplx.ai/maxmasoodi63049
The US trials do not matter for KVUE, they have an agreement with JNJ to get indemnified in case they are found liable in US and Canada. Compensation in lawsuits outside North America is usually much smaller in case of being found liable.
They’re not going to 0, chill. The asbestos baby powder thing is unproven and the UK trials work in a different manner. It’s an actual judge taking a decision with the scientific reasoning and not a jury of common people being influenced by media and outrage. The UK also rarely awards punitive damages. JNJ is appealing all rulings and mostly getting those punitive damages reduced significantly. I own 400 shares of KVUE. This is their main risk, more than anything in the business. Nevertheless, my view at this point is the UK trial needs to be monitored but I believe it won’t move the needle significantly. They’re trying to get 1bn of damages which would be fine for KVUE. Sell if you can’t handle the volatility but I am holding and may buy more. You should’ve done your homework on this before buying though.
[https://www.youtube.com/live/3MbytgHSob0?si=7cug7sKaLv7JNJ6l](https://www.youtube.com/live/3MbytgHSob0?si=7cug7sKaLv7JNJ6l) Live for Trumps speech
[https://www.youtube.com/live/3MbytgHSob0?si=7cug7sKaLv7JNJ6l](https://www.youtube.com/live/3MbytgHSob0?si=7cug7sKaLv7JNJ6l)
oof, hurt by JNJ paper hands
I think today I will chill out, dump my money in JNJ at open. Play BF6 and come pick it up end of day.
Which is so stupid considering one move by China that has very little impact in the near-term is overshadowing the incredible news from JP, Wells Fargo, JNJ, etc. So far, the only bad economic news that impacts anything is GM's loss assumption but that is just based on EVs and not any long-term fundamental problem. But, all of the good economic news is getting ignored so far this morning which is freaking stupid. What China did sucks but it has almost no bearing on anything in the short term which just illustrates more that our market is driven by emotion than actual facts and figures.
This shit sentiment has fucked my DPZ and JNJ calls smh
- ACI Put - JNJ Diagonal Strangle DPZ and ERIC no trade, if I did then a put I think, but it seems priced in to where there won't be enough of a move due to IV crush, etc.
All pharma stocks should print this week JNJ sold a fuck load of GLPs
Spent the afternoon at the driving range working through my weak points from the tourney last week. Pops stopped by, bought a hat, talked shit, then left. He should be the one practicing, but never admits wrong doing. therapist will hear about this. How y’all feeling about JNJ earnings? $200 lottos if I don’t sleep in.
The only ones on my list the held up were Gold, JNJ, PG, TLT, TLH. Gold, long bonds, and non-tech blue chips.
Your best bet is to simply diversify. Buy some foreign ETFs, buy some long term bonds, gold, non-tech blue chip stocks like WMT, XOM, PG, JNJ, JPM, etc, and keep a small amount in tech. If the bubble pops, AI/tech stocks and meme stocks will take big hits, but the rest of the market may be relatively okay. When the dot com bubble burst, the SP500 was down about 35% while the NASDAQ went down 60-70%. The DOW (only 30 stocks) was down less than 20%. Many big blue chip companies continued to climb in value while also paying dividends. Gold continued up.
1. Freeport-McMoRan (FCX) — Copper & critical minerals Why: Tariffs and “America-first” manufacturing push domestic demand for copper and rare earths higher. FCX benefits directly from supply-chain reshoring, infrastructure, and EV grid expansion. Opportunity: Often dips when global growth fears rise, but fundamentals (metal demand, limited new mines) remain strong. Watch zone: Under $45/share is historically a good accumulation area. --- 2. Lockheed Martin (LMT) — Defense & aerospace Why: Political tension and military buildup typically rise during Trump administrations. He tends to increase defense spending and promote domestic defense jobs. Opportunity: The stock is defensive (literally) — stable cash flow and dividends even in volatile markets. Watch zone: Dips near $420–440/share tend to attract long-term buyers. --- 3. Johnson & Johnson (JNJ) — Healthcare & consumer stability Why: A “safe-haven” blue-chip when markets fall; healthcare demand stays steady regardless of policy swings. Opportunity: Currently trades below historical multiples due to litigation overhangs — offers value + dividend yield >3%. Watch zone: Anything below $150/share is considered a strong defensive entry point.
JNJ is doing fine today and they were very likely guilty of their charges. Kennedy himself has admitted that the evidence does not prove causation. Correlation alone is not going to win any court cases. This is a buying opportunity unless you just think the Kenvue business model is in decline without considering the accusations.
Why have I been seeing so many people on here interested in this company lately. What’s so exciting about consumer staples / the old remnants of JNJ’s consumer health products segment at nearly 20 x fwd earnings I mean, okay I guess it’s not a bad long term investment for shares if you’re going to hold it for a decade but why do you guys want to buy calls in this
I would add NBTX (Nanobiotix) to your list. I tried creating a post about it, but I don’t have enough karma in this subreddit. I watched it climb from $10 a few weeks ago— it was $26 when I tried posting and now the next day it’s 31. I used to work at NBTX, they have a JNJ deal, the science is solid and I expect more and more approvals for various cancer indications. Someone in a German WSB mentioned it’s targeted by a Voleon short? And it broke ATH. So I assume that means it’s potential for a squeeze or that it’s already happening? I was hoping for feedback from others since I’m not an expert in short squeezes. I’m already in it.
The question isn't really whether tylenol contributes to autism. It's whether 53% of the country questions tylenol's safety, and is thus less willing to pay a 500-1000% markup over generic or NSAIDs. Remember that KVUE is the company that put asbestos in baby powder for decades after they knew it caused cancer. JNJ spinning off their toxic assets in KVUE looks brilliant in retrospect. The relative stock price performance of JNJ vs KVUE over the past ~3 years since spin is extremely tellingly.
Gonna add JNJ just because Anna Faris RDDT toilet cleaner ads.
JNJ and UNH saving my port today
Well it’s not difficult to check https://preview.redd.it/mjzmzec1tytf1.jpeg?width=638&format=pjpg&auto=webp&s=f865908330f8932f0afe38bcba38c031416995d0 If you have products older than 2 years they may still say JNJ I don’t know, maybe they even still print it on there, not sure. But this happened in 2023.
JNJ no longer makes money from consumer staples, they’re a pharmaceutical company
NVO, LLY, ABBV, JNJ, ... There's a lot of BP left.
$JNJ is about to peg me today
JNJ reporting promising results - stock down 2.5% pre market. Time to buy more
Uh guys JNJ… PG…… what’s happening
https://investorplace.com/2015/06/largest-companies-by-market-cap-facebook-walmart-fb-wmt/#:~:text=Largest%20Companies%20by%20Market%20Cap%202015:%20Facebook,&%20Johnson%20(JNJ)%20*%20General%20Electric%20(GE) Here. I guess you will miss about half of the top performer today. Especially Nvidia and Tesla
Diversify towards dividends and REITs, when it comes to portfolio effect, heavy dividend payers display a lower Beta (ex. JNJ Beta: 0.39\~). Beta lower than 1 react in a non violent manner compared to the over all market. Also if you're in the retirement phase the "real world" effect of a portfolio devaluation is heavily offset by steady dividend payments and can help bridge the gap in down turns. A lot of people discount the "real world" effect and just think about the long term for aspects such as growth stocks and spiraling upwards tech dream. However, when banks sell off non dividend payers since there is no incentive for big money to hold them, you end up playing the DCA game trying to offset the loss, when in reality you need that portfolio to live. It's a lot more than numbers.
No one is paying attention to $JNJ, buy in Monday morning 🤫 $JNJ to $200 by OEM
Puts on JNJ with their biggest baby oil buyer going to prison for 50 months.
Puts on JNJ. Thinking Diddy will get the book thrown at him.
JNJ dropping, not looking good for Diddy
JNJ gonna tank after hours if Diddy gets more than a year
Who tf is playing JNJ calls/puts for the verdict
This is the play: GDRX will ultimately become TrumpRX. USA will take a stake 100% mortal lock. I got 10,000 shares for now JNJ will make a deal for direct drug access. INTC probably still gonna approach some other schmucks for chip work
JNJ is next to make a deal. Trump will probably make govt take a stake in GDRx and change its name
Fellow regards I have been given a 2% green pick yesterday (PFE). Time to get opinions on the next one. Is JNJ good for 2% scalp?
Anybody have thoughts on JNJ continuing up through and after earnings?
JNJ was the play. Good luck all the same
What’s up with JNJ?! My dumbass sold my 185 calls for a loss yesterday now they’re worth $200 each 😭 I hate it here
Next time JNJ will be doing same "donations" than CBD companies
They tried to do that with a seperate subsidiary but were shut down, not the Kenvue split. JNJ retained talc liability in the US/Canada. Kenvue split off for different reasons..my take is the two businesses were so unrelated, it would be hard for management to focus/prioritize both.. Maybe it strengthens their case though insofar as it might push folks to accept a settlement. You got a pharma/device company now (JNJ) trying to settle and every year that goes by they are distancing themselves in time from an old business they aren't even part of anymore.
JNJ kept most of the liability actually.
Man, I looked into this. From what I understand JNJ says they want to focus more on the higher margin stuff and less on the over the counter aspects of their business. So it's meant to look like Kenvue can be more agile as it's a smaller more focuses company. But, I can't help but wonder that JNJ knew something was cooking with the whole Tylenol austism thing and dumped this part of their business to get away from the heat. Now is the correlation between Tylenol and autism true? I can't take Kennedy or Trump as being knowledgeable about anything related to healthcare. Nor do I believe this administration has out best interest in heart. So I am staying away from it. This isn't another Cracker Barrel.
What this tells me is that JNJ is great at financial engineering.
Tylenol is only 9% of their revenue. JNJ spun off all their CPG so that JNJ focused on B2B.
KVUE has been struggling since the spin off from JNJ. They have so much debt and this isn’t even even a growth stock
I think JNJ is a nice longer position because of... [https://www.jnj.com/media-center/press-releases/johnson-johnson-seeks-first-icotrokinra-u-s-fda-approval-aiming-to-revolutionize-treatment-paradigm-for-adults-and-adolescents-with-plaque-psoriasis](https://www.jnj.com/media-center/press-releases/johnson-johnson-seeks-first-icotrokinra-u-s-fda-approval-aiming-to-revolutionize-treatment-paradigm-for-adults-and-adolescents-with-plaque-psoriasis)
Lots of commenters can't read a balance sheet or income statement and it shows. This is a good long term hold; it's a cash cow. However, in this market of animal spirits and vibes, it's not tech so why bother? There's a ton of debt at this company (thanks, JNJ) and no growth. This is just a boring old cash cow, which is why JNJ spun it out. OP - just buy some tech. Way easier ways to make money in this market.
My cost is around $9 from the JNJ tender, and I bought more yesterday at $17. It’s worth about $25 to a P&G or foreign consumer brand, or JNJ can just pay $20 in stock and profit from the drop in price.
It’s weird that JNJ spun this off. Makes me not want to own either stock tbh
JNJ don't give a fuuuu its going up
I thought JNJ was supposed to crater :,(
do you guys think mango bought puts on JNJ and other OTC/pharma distributors right before announcing the tenuous link between Tylenol and autism? 🤔
KVUE & JNJ stock both correlate with Tylenol and both are pumping right now lmao
I was gonna say, all this time I thought Tylenol was JNJ
Kenvue has been awful since the JNJ spinoff. I was pissed the way that spinoff was handled and ending up selling all my JNJ shares and never touched Kenvue either as a result.
$KVUE not $JNJ. They spun-off that part of the business a couple years ago.
JNJ puts for Tylenol getting destroyed or calls for their slam dunk lawsuit over the presser?
Which degens are about to Yolo into KVUE? And which Highly Artistic Degens plan to yolo into JNJ?